Prestige Biologics Co., Ltd. (KOSDAQ:334970)
 2,985.00
 -15.00 (-0.50%)
  Last updated: Oct 30, 2025, 12:19 PM KST
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 234.42 billion as of October 30, 2025. Its market cap has decreased by -35.94% in one year.
Market Cap 
 234.42B
Enterprise Value 
 324.30B
Revenue 
 12.53B
Ranking 
 n/a
PE Ratio 
 n/a
Stock Price 
2,985.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 234.42B, a decrease of -61.77%. That is a compound annual growth rate of -18.72%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 234.42B | -40.51% | 
| Dec 30, 2024 | 394.06B | 46.25% | 
| Dec 28, 2023 | 269.45B | 46.01% | 
| Dec 29, 2022 | 184.55B | -59.28% | 
| Dec 30, 2021 | 453.18B | -26.10% | 
| Mar 11, 2021 | 613.27B | - | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Samsung Electronics | 647.62T | 
| SK hynix | 359.70T | 
| LG Energy Solution | 119.34T | 
| Samsung Biologics | 87.69T | 
| Doosan Enerbility | 55.34T | 
| Hyundai Motor Company | 54.66T | 
| HD Hyundai Heavy Industries | 52.73T | 
| Hanwha Aerospace | 51.24T |